Oxidation of Aβ and plaque biogenesis in Alzheimer's disease and Down syndrome

Neurobiology of Disease

Volumn 8, Issue 5, 2001, Pages 792-806

  Head, Elizabeth ^a   Garzon Rodriguez, William ^a,b   Johnson, Julene K ^a   Lott, Ira T ^a   Cotman, Carl W ^a   Glabe, Charles ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Alzheimer's disease; Amyloid; Brain aging; Canine; Down syndrome; Microglia, oxidative damage

Indexed keywords

AMYLOID BETA PROTEIN; POLYCLONAL ANTIBODY; SYNTHETIC PEPTIDE; HLA DR ANTIGEN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BIOGENESIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; HUMAN TISSUE; MALE; MENTAL DEFICIENCY; MICROGLIA; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SENILE PLAQUE; BRAIN; CHEMISTRY; CONFOCAL MICROSCOPY; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; DOWN SYNDROME; HLA-DR ANTIGENS; HUMANS; MICROGLIA; MICROSCOPY, CONFOCAL; OXIDATION-REDUCTION; SENILE PLAQUES;

EID: 0034746895     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0431     Document Type: Article

References (75)

1. β-Amyloid (β/A4) deposition in the medial temporal lobe in Down's syndrome: Effects of brain region and patient age
2. Molecular dating of senile plaques in aged Down's syndrome and canine brains
3. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease
4. Hydrogen peroxide mediates amyloid beta protein toxicity
5. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs
6. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid β-peptide by microglial cells
7. Lipoprotein effects on Aβ accumulation and degradation by microglia in vitro
8. Image analysis of beta-amyloid "load" in Alzheimer's disease and relation to dementia severity
9. The canine as an animal model of human aging and dementia
10. βA4 accumulation in aged canine brain: An model of plaque formation in Alzheimer's disease
11. Alzheimer neuropathologic alterations in aged cognitively normal subjects
12. Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person
13. Identification of normal and pathological aging in prospectively studied nondemented elderly humans
14. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation
15. Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease
16. Scavenger receptor mediated adhesion of microglia to beta-amyloid fibrils
17. Mini-mental state: A practical method for grading the cognitive status of patients for the clinician
18. The presence of isoaspartic acid in β-amyloid plaques indicates plaque age
19. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils
20. In vitro peroxidase oxidation induces stable dimers of β-amyloid (1-42) through dityrosine bridge formation
21. Alzheimer's disease and Down's syndrome sharing of a unique cerebrovascular amyloid fibril protein
22. Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion
23. Region-specific age at onset of β-amyloid in dogs
24. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome
25. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction
26. Evidence of amyloid β-protein immunoreactive early plaque lesions in Down's syndrome brains
27. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
28. Full-length amyloid-β-(1-42(43)) and amino-terminally modified and truncated amyloid-β42(43) deposits in diffuse plaques
29. Human phagocytes employ the myeloperoxidase-hydrogen peroxide system to synthesize dityrosine, trityrosine, pulcherosine, and isodityrosine by a tyrosyl radical-dependent pathway
30. The blood-brain barrier and cerebral microcirculation in Alzheimer's disease
31. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
32. Diagnosis of Alzheimer's disease
33. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids
34. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein
35. A prospective study of Alzheimer disease in Down syndrome
36. Sequence of deposition of heterogeneous amyloid beta-peptides and APOE in Down syndrome: Implications for initial events in amyloid plaque formation
37. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide
38. The pathological association between Down syndrome and Alzheimer disease
39. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome
40. Immunohistochemcial localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy
41. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
42. Racemization: Its biological significance on neuropathogenesis of Alzheimer's disease
43. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Clinical and neuropsychological assessment of Alzheimer's disease
44. Increased senile plaques without microglia in Alzheimer's disease
45. Slow degradation of aggregates of the Alzheimer's disease amyloid β-protein by microglial cells
46. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor
47. Mass spectrometric quantification of 3-nitrotyrosine, orthotyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease
48. Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease
49. Mild cognitive impairment: Clinical characterization and outcome
50. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease
51. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease
52. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease
53. A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid deposition
54. Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain
55. The progression of beta-amyloid deposition in the frontal cortex of the aged canine
56. Tricine-sodium dodecyl sulfate-polyacrylamide gel eletrophoresis for the separation of proteins in the range of 1 to 100 kDa
57. Immunization with amyloid-β attentuates Alzheimer-disease-like pathology in the PDAPP mouse
58. Normal and abnormal biology of the beta-amyloid precursor protein
59. Amyloid beta-protein and the genetics of Alzheimer's disease
60. Neuritic plaque amyloid in Alzheimer's disease is highly racemized
61. Reactive microglia/macrophages phagocytose amyloid precursor protein produced by neurons following neural damage
62. Reactive microgliosis
63. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain
64. N-terminal heterogeneity of parenchymal and cerebrovascular Aβ deposits
65. Consensus recommendations for the post mortem diagnosis of Alzheimer's disease
66. Controlling amyloid beta-peptide fibril formation with protease-stable ligands
67. 23 residue affects the aggregation properties of Alzheimer amyloid β protein analogues
68. Simultaneous demonstration of multiple antigens by indirect immunofluorescence or immunogold staining
69. The complex of microglial cells and amyloid star in three-dimensional reconstruction
70. Precocious aging and dementia in patients with Down's syndrome
71. Ultrastructural studies of the cells forming amyloid fibers in classical plaques
72. Intracellular Abeta 1-42 aggregates stimulate the accumulation of stable insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells
73. Intracellular accumulation of insoluble, newly synthesized abeta n-42 in amyloid precursor protein-transfected cells that have been treated with Abeta1-42
74. Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species
75. Mechanisms of neuronal degeneration in Alzheimer's disease